arginine and s 1033

arginine has been researched along with s 1033 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Nader, MA; Wagih, HM	1

Reviews

1 review(s) available for arginine and s 1033

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

1 other study(ies) available for arginine and s 1033

Article	Year
Nilotinib, a tyrosine kinase inhibitor exhibits protection against acute pancreatitis-induced lung and liver damage in rats. Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:3 Topics: Acute Disease; Amylases; Animals; Anti-Inflammatory Agents; Antioxidants; Arginine; Biomarkers; Cytoprotection; Disease Models, Animal; Lipase; Liver Diseases; Lung Injury; Male; NF-kappa B; Nitrates; Nitrites; Pancreatitis; Protein Kinase Inhibitors; Pyrimidines; Rats, Sprague-Dawley; Time Factors; Transforming Growth Factor beta1	2017

Article

Year

Nilotinib, a tyrosine kinase inhibitor exhibits protection against acute pancreatitis-induced lung and liver damage in rats.

Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:3

Topics: Acute Disease; Amylases; Animals; Anti-Inflammatory Agents; Antioxidants; Arginine; Biomarkers; Cytoprotection; Disease Models, Animal; Lipase; Liver Diseases; Lung Injury; Male; NF-kappa B; Nitrates; Nitrites; Pancreatitis; Protein Kinase Inhibitors; Pyrimidines; Rats, Sprague-Dawley; Time Factors; Transforming Growth Factor beta1

2017